Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 16,258,000 | 17,032,000 | 16,495,000 | 16,220,000 | 15,651,000 |
| Cost of Goods | 14,072,000 | 14,818,000 | 14,359,000 | 14,007,000 | 13,560,000 |
| Gross Profit | 2,186,000 | 2,214,000 | 2,136,000 | 2,213,000 | 2,091,000 |
| Operating Expenses | 4,000 | -75,000 | -11,000 | 127,000 | -31,000 |
| Operating Income | 2,182,000 | 2,289,000 | 2,147,000 | 2,086,000 | 2,122,000 |
| Interest Expense | 140,000 | 149,000 | 145,000 | 149,000 | 148,000 |
| Other Income | 169,000 | 47,000 | 54,000 | 25,000 | 56,000 |
| Pre-tax Income | 2,211,000 | 2,187,000 | 2,056,000 | 1,962,000 | 2,030,000 |
| Income Tax | 374,000 | 395,000 | 303,000 | 336,000 | 313,000 |
| Net Income Continuous | 1,837,000 | 1,792,000 | 1,753,000 | 1,626,000 | 1,717,000 |
| Net Income Discontinuous | N/A | 0 | -55,000 | N/A | N/A |
| Net Income | $1,837,000 | $1,792,000 | $1,698,000 | $1,626,000 | $1,717,000 |
| EPS Basic Total Ops | 0.28 | 0.27 | 0.26 | 0.25 | 0.26 |
| EPS Basic Continuous Ops | 0.28 | 0.27 | 0.26 | 0.25 | 0.26 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | -0.01 | N/A | N/A |
| EPS Diluted Total Ops | 0.28 | 0.27 | 0.26 | 0.24 | 0.26 |
| EPS Diluted Continuous Ops | 0.28 | 0.27 | 0.26 | 0.24 | 0.26 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | -0.01 | N/A | N/A |
| EBITDA(a) | $2,687,000 | $2,699,000 | $2,520,000 | $2,418,000 | $2,479,000 |